JPRN-UMIN000020677尚未招募未知
Verteporfin photodynamic therapy for central serous chorioretinopathy - PDT for CSC
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with other retinal diseases photosensitivity
研究者
相似试验
尚未招募
不适用
Photodynamic therapy for central serous chorioretinopathy, idiopathic choroidal neovascular disease, myopic choroidal neovascular diseaseCentral serous chorioretinopathyJPRN-UMIN000026850Toho University Omori Medical Center40
已完成
2 期
Photodynamic therapy with half dose verteporfin for central serous chorioretinopathy:Prospective intervention trialCentral serous chorioretinopathyJPRN-UMIN000002229agoya University School of Medicine Department of Ophthalmology10
已完成
2 期
Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)Chronic Central Serous ChorioretinopathyNCT00211445Manhattan Eye, Ear & Throat Hospital11
进行中（未招募）
1 期
A Phase 1 Trial of Verteporfin Photodynamic Therapy in Unresectable Pancreatic Carcinoma (VERTPAC-01 study) - VERTPAC-01EUCTR2006-004097-28-GBniversity College Hospitals NHS Foundation Trust/ University College London12
招募中
不适用
Reduced-Fluence Photodynamic Therapy for Central Serous Chorioretinopathy(CSC) and Multifocal Posterior Pigment Epitheliopathy(MPPE)JPRN-UMIN000015283Okayama University Hospital30